Mirco Ponzoni

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Cancers

Journal of translational medicine

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mario Capasso, Chiara Brignole, Vito A Lasorsa, Veronica Bensa, Sueva Cantalupo, Enrico Sebastiani, Alessandro Quattrone, Eleonora Ciampi, Marianna Avitabile, Angela R Sementa, Katia Mazzocco, Barbara Cafferata, Gabriele Gaggero, Valerio G Vellone, Michele Cilli, Enzo Calarco, Elena Giusto, Patrizia Perri, Sanja Aveic, Doriana Fruci, Annalisa Tondo, Roberto Luksch, Rossella Mura, Marco Rabusin, Francesco De Leonardis, Monica Cellini, Paola Coccia, Achille Iolascon, Maria V Corrias, Massimo Conte, Alberto Garaventa, Loredana Amoroso, Mirco Ponzoni, Fabio Pastorino
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models. Journal of translational medicine 22 (1) (2024)
Mario Capasso, Chiara Brignole, Vito A Lasorsa, Veronica Bensa, Sueva Cantalupo, Enrico Sebastiani, Alessandro Quattrone, Eleonora Ciampi, Marianna Avitabile, Angela R Sementa, Katia Mazzocco, Barbara Cafferata, Gabriele Gaggero, Valerio G Vellone, Michele Cilli, Enzo Calarco, Elena Giusto, Patrizia Perri, Sanja Aveic, Doriana Fruci, Annalisa Tondo, Roberto Luksch, Rossella Mura, Marco Rabusin, Francesco De Leonardis, Monica Cellini, Paola Coccia, Achille Iolascon, Maria V Corrias, Massimo Conte, Alberto Garaventa, Loredana Amoroso, Mirco Ponzoni, Fabio Pastorino
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models. Journal of translational medicine 22 (1) (2024)
Mario Capasso, Chiara Brignole, Vito A Lasorsa, Veronica Bensa, Sueva Cantalupo, Enrico Sebastiani, Alessandro Quattrone, Eleonora Ciampi, Marianna Avitabile, Angela R Sementa, Katia Mazzocco, Barbara Cafferata, Gabriele Gaggero, Valerio G Vellone, Michele Cilli, Enzo Calarco, Elena Giusto, Patrizia Perri, Sanja Aveic, Doriana Fruci, Annalisa Tondo, Roberto Luksch, Rossella Mura, Marco Rabusin, Francesco De Leonardis, Monica Cellini, Paola Coccia, Achille Iolascon, Maria V Corrias, Massimo Conte, Alberto Garaventa, Loredana Amoroso, Mirco Ponzoni, Fabio Pastorino
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models. Journal of translational medicine 22 (1) (2024)
Mario Capasso, Chiara Brignole, Vito A Lasorsa, Veronica Bensa, Sueva Cantalupo, Enrico Sebastiani, Alessandro Quattrone, Eleonora Ciampi, Marianna Avitabile, Angela R Sementa, Katia Mazzocco, Barbara Cafferata, Gabriele Gaggero, Valerio G Vellone, Michele Cilli, Enzo Calarco, Elena Giusto, Patrizia Perri, Sanja Aveic, Doriana Fruci, Annalisa Tondo, Roberto Luksch, Rossella Mura, Marco Rabusin, Francesco De Leonardis, Monica Cellini, Paola Coccia, Achille Iolascon, Maria V Corrias, Massimo Conte, Alberto Garaventa, Loredana Amoroso, Mirco Ponzoni, Fabio Pastorino
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models. Journal of translational medicine 22 (1) (2024)
Chiara Brignole, Enzo Calarco, Veronica Bensa, Elena Giusto, Patrizia Perri, Eleonora Ciampi, Maria Valeria Corrias, Simonetta Astigiano, Michele Cilli, Derik Loo, Ezio Bonvini, Fabio Pastorino, Mirco Ponzoni
Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma. Journal for immunotherapy of cancer 11 (9) (2023)
Fabio Pastorino, Mario Capasso, Chiara Brignole, Vito Alessandro Lasorsa, Veronica Bensa, Patrizia Perri, Sueva Cantalupo, Serena Giglio, Massimo Provenzi, Marco Rabusin, Elvira Pota, Monica Cellini, Annalisa Tondo, Maria Antonietta De Ioris, Angela R Sementa, Alberto Garaventa, Mirco Ponzoni, Loredana Amoroso
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology. Cancers 15 (3) (2023)
Fabio Pastorino, Mario Capasso, Chiara Brignole, Vito Alessandro Lasorsa, Veronica Bensa, Patrizia Perri, Sueva Cantalupo, Serena Giglio, Massimo Provenzi, Marco Rabusin, Elvira Pota, Monica Cellini, Annalisa Tondo, Maria Antonietta De Ioris, Angela R Sementa, Alberto Garaventa, Mirco Ponzoni, Loredana Amoroso
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology. Cancers 15 (3) (2023)
Fabio Pastorino, Mario Capasso, Chiara Brignole, Serena Giglio, Veronica Bensa, Sueva Cantalupo, Vito Alessandro Lasorsa, Annalisa Tondo, Rossella Mura, Angela Rita Sementa, Alberto Garaventa, Mirco Ponzoni, Loredana Amoroso
Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations. International journal of molecular sciences 23 (19) (2022)
Massimo Moro, Orazio Fortunato, Giulia Bertolini, Mavis Mensah, Cristina Borzi, Giovanni Centonze, Francesca Andriani, Daniela Di Paolo, Patrizia Perri, Mirco Ponzoni, Ugo Pastorino, Gabriella Sozzi, Mattia Boeri
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Enrico Rango, Fabio Pastorino, Chiara Brignole, Arianna Mancini, Federica Poggialini, Salvatore Di Maria, Claudio Zamperini, Giulia Iovenitti, Anna Lucia Fallacara, Samantha Sabetta, Letizia Clementi, Massimo Valoti, Silvia Schenone, Adriano Angelucci, Mirco Ponzoni, Elena Dreassi, Maurizio Botta
The Pyrazolo[3,4- d ]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma. Biomedicines 10 (3) (2022)
Fabio Morandi, Veronica Bensa, Enzo Calarco, Fabio Pastorino, Patrizia Perri, Maria Valeria Corrias, Mirco Ponzoni, Chiara Brignole
The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis. Nutrients 13 (7) (2021)
Veronica Bensa, Enzo Calarco, Elena Giusto, Patrizia Perri, Maria Valeria Corrias, Mirco Ponzoni, Chiara Brignole, Fabio Pastorino
Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Chiara Brignole, Fabio Pastorino, Patrizia Perri, Loredana Amoroso, Veronica Bensa, Enzo Calarco, Mirco Ponzoni, Maria Valeria Corrias
Bone Marrow Environment in Metastatic Neuroblastoma. Cancers 13 (10) (2021)
Patrizia Perri, Mirco Ponzoni, Maria Valeria Corrias, Isabella Ceccherini, Simona Candiani, Tiziana Bachetti
A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma. Cancers 13 (21) (2021)
Emily Capone, Alessia Lamolinara, Fabio Pastorino, Roberta Gentile, Sara Ponziani, Giulia Di Vittorio, Daniela D'Agostino, Sandra Bibbò, Cosmo Rossi, Enza Piccolo, Valentina Iacobelli, Rossano Lattanzio, Valeria Panella, Michele Sallese, Vincenzo De Laurenzi, Francesco Giansanti, Arturo Sala, Manuela Iezzi, Mirco Ponzoni, Rodolfo Ippoliti, Stefano Iacobelli, Gianluca Sala
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers 12 (10) (2020)
Samira Tarashi, Seyed Davar Siadat, Sara Ahmadi Badi, Mohammadreza Zali, Roberto Biassoni, Mirco Ponzoni, Arfa Moshiri
Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? Microorganisms 7 (11) (2019)
Fabio Pastorino, Chiara Brignole, Daniela Di Paolo, Patrizia Perri, Flavio Curnis, Angelo Corti, Mirco Ponzoni
Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers. Small (Weinheim an der Bergstrasse, Germany) 15 (10) (2019)
Mirco Ponzoni, Fabio Pastorino, Daniela Di Paolo, Patrizia Perri, Chiara Brignole
Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer. International journal of molecular sciences 19 (7) (2018)
Fabio Morandi, Loredana Amoroso, Alessandra Dondero, Roberta Castriconi, Stefano Parodi, Roberto Luksch, Fiorina Casale, Aurora Castellano, Alberto Garaventa, Alessandro Moretta, Cristina Bottino, Mirco Ponzoni, Maria Valeria Corrias
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma. Oncoimmunology 7 (9) (2018)

Mirco Ponzoni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mirco Ponzoni